Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, by Type (Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1071381
  • |
  • Publishe Date : June 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Peripheral Arterial Disease (PAD) Therapeutics Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increasing prevalence of Cardiac diseases is boosting the market growth. However the high cost of therapy might restraint the market growth.

The global peripheral arterial disease (PAD) therapeutics market is primarily segmented based on type and regions.

On the basis of type, the market is split into:
* Peripheral Angioplasty Balloons (Old/Normal Balloons, Cutting and Scoring Balloons, Drug Coated Balloons)
* Peripheral Stents (Self Expandable, Balloon Expandable, Covered, Drug Eluting Stents)
* Peripheral Catheters (Angiography Catheters, Guiding Catheters)
* Inferior Vena Cava Filters (Permanent Filters, Retrievable Filters)
* Other Types

Moreover, the market is classified based on region and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* AstraZeneca plc
* Abbott Laboratories
* Boston Scientific Corporation
* Cook Medical Incorporated
* Cardinal Health, Inc.
* C. R. Bard, Inc.
* Medtronic plc
* Terumo Corporation
* Spectranetics Corporation
* Biotronik

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions type and options with qualitative and quantitative information and facts

Target Audience:
* Peripheral Arterial Disease (PAD) Therapeutics Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Peripheral Arterial Disease (PAD) Therapeutics Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market - Porter\'s Five Forces Analysis
4.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market - PESTEL Analysis

5. Global Peripheral Arterial Disease (PAD) Therapeutics Market, by Type
5.1. Global Peripheral Arterial Disease (PAD) Therapeutics Market, Size and Forecast, 2015-2026
5.2. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Peripheral Angioplasty Balloons, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.2.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Old/Normal Balloons, 2015-2026
5.2.3.1. Market size and forecast, 2015-2026
5.2.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Cutting and Scoring Balloons, 2015-2026
5.2.4.1. Market size and forecast, 2015-2026
5.2.5. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Drug Coated Balloons, 2015-2026
5.2.5.1. Market size and forecast, 2015-2026
5.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Peripheral Stents, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.3.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Self Expandable, 2015-2026
5.3.3.1. Market size and forecast, 2015-2026
5.3.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Balloon Expandable, 2015-2026
5.3.4.1. Market size and forecast, 2015-2026
5.3.5. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Covered, 2015-2026
5.3.5.1. Market size and forecast, 2015-2026
5.3.6. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Drug Eluting Stents, 2015-2026
5.3.6.1. Market size and forecast, 2015-2026
5.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Peripheral Catheters, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.4.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Angiography Catheters, 2015-2026
5.4.3.1. Market size and forecast, 2015-2026
5.4.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Guiding Catheters, 2015-2026
5.4.4.1. Market size and forecast, 2015-2026
5.5. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Inferior Vena Cava Filters, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.5.3. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Permanent Filters, 2015-2026
5.5.3.1. Market size and forecast, 2015-2026
5.5.4. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Retrievable Filters, 2015-2026
5.5.4.1. Market size and forecast, 2015-2026
5.6. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Other Types, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global Peripheral Arterial Disease (PAD) Therapeutics Market by Region
6.1. Peripheral Arterial Disease (PAD) Therapeutics Market Regional Analysis, 2015-2026
6.2. Global Peripheral Arterial Disease (PAD) Therapeutics Market Revenue (USD Million) by Region, 2015-2026
6.3. North America Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.3.1. North America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast, 2015-2026
6.3.2. North America Peripheral Arterial Disease (PAD) Therapeutics Market by Country, 2015-2026
6.3.2.1. U.S. Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.3.2.2. Canada Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4. Europe Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.1. Europe Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast, 2015-2026
6.4.2. Europe Peripheral Arterial Disease (PAD) Therapeutics Market by Country, 2015-2026
6.4.2.1. Germany Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.2.2. France Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.2.3. Italy Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.2.4. UK Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.2.5. Spain Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.4.2.6. Rest of Europe Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.5. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.5.1. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast, 2015-2026
6.5.2. Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market by Country, 2015-2026
6.5.2.1. Japan Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.5.2.2. China Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.5.2.3. India Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.5.2.4. Rest of Asia Pacific Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.6. South America Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.6.1. South America Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast, 2015-2026
6.6.2. South America Peripheral Arterial Disease (PAD) Therapeutics Market by Country, 2015-2026
6.6.2.1. Mexico Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.6.2.2. Brazil Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.6.2.3. Rest of South America Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.7. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.7.1. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market Size and Forecast, 2015-2026
6.7.2. Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market by Country, 2015-2026
6.7.2.1. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.7.2.2. South Africa Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026
6.7.2.3. Rest of Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Market, 2015-2026

7. Competitive Landscape
7.1. Introduction
7.2. Market Share Analysis/Top Player Positioning, 2018

8. Company Profiles
8.1. AstraZeneca plc
8.1.1. Company Overview
8.1.2. Financial Overview
8.1.3. Product Benchmarking
8.1.4. Key Developments
8.2. Abbott Laboratories
8.2.1. Company Overview
8.2.2. Financial Overview
8.2.3. Product Benchmarking
8.2.4. Key Developments
8.3. Boston Scientific Corporation
8.3.1. Company Overview
8.3.2. Financial Overview
8.3.3. Product Benchmarking
8.3.4. Key Developments
8.4. Cook Medical Incorporated
8.4.1. Company Overview
8.4.2. Financial Overview
8.4.3. Product Benchmarking
8.4.4. Key Developments
8.5. Cardinal Health, Inc.
8.5.1. Company Overview
8.5.2. Financial Overview
8.5.3. Product Benchmarking
8.5.4. Key Developments
8.6. C. R. Bard, Inc.
8.6.1. Company Overview
8.6.2. Financial Overview
8.6.3. Product Benchmarking
8.6.4. Key Developments
8.7. Medtronic plc
8.7.1. Company Overview
8.7.2. Financial Overview
8.7.3. Product Benchmarking
8.7.4. Key Developments
8.8. Terumo Corporation
8.8.1. Company Overview
8.8.2. Financial Overview
8.8.3. Product Benchmarking
8.8.4. Key Developments
8.9. Spectranetics Corporation
8.9.1. Company Overview
8.9.2. Financial Overview
8.9.3. Product Benchmarking
8.9.4. Key Developments
8.10. Biotronik
8.10.1. Company Overview
8.10.2. Financial Overview
8.10.3. Product Benchmarking
8.10.4. Key Developments

9. Key Insights

Content are not available

Choose License Type